ECOLAB INC.
Business
Ecolab is a global leader in water, hygiene and infection prevention solutions and services, operating across more than 170 countries and 40 industries. The company provides cleaning and sanitizing products, water treatment solutions, pest elimination services, and contamination control products to customers in food and beverage processing, hospitality, healthcare, data centers, microelectronics, life sciences and other industrial sectors. Operating through four reportable segments—Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences—Ecolab combines science-based chemistry, digital monitoring technology and field service expertise to help customers optimize operational performance while reducing water and energy use.
Summary from 10-K filed 2026-02-23
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net sales | 16,081 | 15,741 | 15,320 | 14,188 | 12,733 | |
| Cost of sales (including special charges (a)) | 8,931 | 8,900 | 9,155 | 8,831 | 7,616 | |
| Selling, general and administrative expenses | 4,258 | 4,228 | 4,062 | 3,654 | 3,416 | |
| Special (gains) and charges | 155 | −189 | 111 | 141 | 103 | |
| Operating income | 2,738 | 2,802 | 1,992 | 1,563 | 1,599 | |
| Other (income) expense | −51 | −51 | −60 | −25 | −34 | |
| Interest expense, net | 241 | 283 | 297 | 244 | 218 | |
| Income before income taxes | 2,548 | 2,571 | 1,756 | 1,343 | 1,414 | |
| Provision for income taxes | 455 | 439 | 363 | 235 | 270 | |
| Net income including noncontrolling interest | 2,093 | 2,132 | 1,393 | 1,109 | 1,144 | |
| Net income attributable to noncontrolling interest | 18 | 20 | 21 | 17 | 14 | |
| Net income attributable to Ecolab | 2,076 | 2,112 | 1,372 | 1,092 | 1,130 | |
| Basic (in dollars per share) | 7.33 | 7.43 | 4.82 | 3.83 | 3.95 | |
| Diluted EPS (in dollars per share) | 7.28 | 7.37 | 4.79 | 3.81 | 3.91 | |
| Basic (in shares) | 283 | 284 | 285 | 285 | 286 | |
| Diluted (in shares) | 285 | 287 | 287 | 287 | 289 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 646 | 1,257 | 920 | 599 | 360 | |
| Accounts receivable, net | 3,249 | 2,865 | 2,834 | 2,698 | 2,478 | |
| Inventories | 1,490 | 1,465 | 1,497 | 1,793 | 1,492 | |
| Other current assets | 570 | 439 | 393 | 405 | 357 | |
| Total current assets | 5,956 | 6,026 | 5,644 | 5,494 | 4,687 | |
| Property, plant and equipment, net | 4,277 | 3,752 | 3,475 | 3,293 | 3,289 | |
| Goodwill | 9,227 | 7,907 | 8,148 | 8,013 | 8,064 | |
| Other intangible assets, net | 3,689 | 3,309 | 3,494 | 3,681 | 4,224 | |
| Operating lease assets | 766 | 723 | 554 | 448 | 397 | |
| Other assets | 783 | 670 | 533 | 535 | 546 | |
| Total assets | 24,696 | 22,388 | 21,847 | 21,464 | 21,206 | |
| Short-term debt | 870 | 616 | 630 | 505 | 411 | |
| Accounts payable | 2,071 | 1,810 | 1,566 | 1,728 | 1,384 | |
| Compensation and benefits | 722 | 727 | 656 | 494 | 510 | |
| Income taxes | 134 | 127 | 159 | 198 | 104 | |
| Other current liabilities | 1,738 | 1,513 | 1,335 | 1,286 | 1,144 | |
| Total current liabilities | 5,535 | 4,793 | 4,346 | 4,210 | 3,553 | |
| Long-term debt | 7,366 | 6,949 | 7,551 | 8,075 | 8,347 | |
| Pension and postretirement benefits | 546 | 635 | 652 | 670 | 894 | |
| Deferred income taxes | 330 | 280 | 418 | 506 | 622 | |
| Operating lease liabilities | 597 | 576 | 426 | 338 | 283 | |
| Other liabilities | 519 | 366 | 382 | 406 | 254 | |
| Total liabilities | 14,892 | 13,599 | 13,774 | 14,206 | 13,953 | |
| Commitments and contingencies (Note 15) | — | — | — | — | — | |
| Common stock | 369 | 368 | 366 | 365 | 364 | |
| Additional paid-in capital | 7,521 | 7,160 | 6,767 | 6,580 | 6,465 | |
| Retained earnings | 12,834 | 11,517 | 10,075 | 9,319 | 8,815 | |
| Accumulated other comprehensive loss | −1,874 | −1,982 | −1,850 | −1,727 | −1,635 | |
| Treasury stock | −9,080 | −8,305 | −7,313 | −7,301 | −6,784 | |
| Total Ecolab shareholders' equity | 9,771 | 8,757 | 8,045 | 7,236 | 7,224 | |
| Noncontrolling interest | 34 | 32 | 28 | 23 | 29 | |
| Total equity | 9,805 | 8,789 | 8,072 | 7,259 | 7,253 | |
| Total liabilities and equity | 24,696 | 22,388 | 21,847 | 21,464 | 21,206 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation | 673 | 635 | 617 | 619 | 604 | |
| Amortization | 304 | 301 | 307 | 320 | 239 | |
| Deferred income taxes | −33 | −191 | −56 | −143 | −1 | |
| Share-based compensation expense | 137 | 135 | 95 | 88 | 90 | |
| Pension and postretirement plan contributions | −78 | −54 | −109 | −64 | −60 | |
| Pension and postretirement plan expense (income), net | 15 | 14 | 3 | 46 | 42 | |
| Restructuring charges, net of cash paid | 19 | 24 | −33 | 66 | −42 | |
| Sale of global surgical solutions business | 1 | −382 | — | — | — | |
| Other, net | 29 | 24 | 32 | 25 | 16 | |
| Accounts receivable | −186 | −147 | −84 | −320 | −178 | |
| Inventories | 36 | −116 | 320 | −403 | −73 | |
| Other assets | 84 | −24 | 72 | −278 | −93 | |
| Accounts payable | 68 | 300 | −232 | 395 | 200 | |
| Other liabilities | −208 | 163 | 87 | 329 | 144 | |
| Cash provided by operating activities | 2,953 | 2,814 | 2,412 | 1,788 | 2,062 | |
| Capital expenditures | −1,048 | −995 | −775 | −713 | −643 | |
| Property and other assets sold | 52 | 11 | 10 | 2 | 12 | |
| Acquisitions and investments in affiliates, net of cash acquired | −1,621 | −313 | −180 | −7 | −3,924 | |
| Divestiture of businesses, net of cash divested | −15 | 890 | — | — | — | |
| Other, net | −75 | −27 | −45 | 1 | −25 | |
| Cash used for investing activities | −2,707 | −434 | −991 | −717 | −4,580 | |
| Net issuances (repayments) of commercial paper and notes payable | 98 | 2 | −2 | −404 | 394 | |
| Long-term debt borrowings | 1,046 | — | — | 494 | 2,775 | |
| Long-term debt repayments | −674 | −630 | −500 | — | −1,018 | |
| Reacquired shares | −784 | −987 | −14 | −518 | −107 | |
| Dividends paid | −754 | −664 | −617 | −603 | −566 | |
| Exercise of employee stock options | 228 | 259 | 97 | 29 | 144 | |
| Hedge settlements | — | −600,000 | −15 | 172 | 26 | |
| Other, net | −14 | −4 | −3 | −7 | −15 | |
| Cash used for financing activities | −853 | −2,024 | −1,055 | −837 | 1,603 | |
| Effect of exchange rate changes on cash and cash equivalents | −3 | −19 | −46 | 4 | 14 | |
| (Decrease) Increase in cash and cash equivalents | −611 | 337 | 321 | 239 | — | |
| Income taxes paid | 548 | 647 | 469 | 309 | 276 | |
| Net interest paid | 303 | 343 | 325 | 222 | 209 |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is ECOLAB INC.'s CIK number?
ECOLAB INC.'s SEC CIK number is 0000031462 (31462). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find ECOLAB INC.'s SEC filings?
All of ECOLAB INC.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did ECOLAB INC. last report earnings?
ECOLAB INC. (ECL) most recently filed an earnings 8-K with the SEC on Apr 28, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001104659-26-049822). This is ECOLAB INC.'s most recent earnings filing of record — not a forecast of its next earnings date.
What is ECOLAB INC.'s most recent earnings 8-K?
ECOLAB INC.'s latest earnings 8-K (Item 2.02) was filed Apr 28, 2026 under accession 0001104659-26-049822. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View ECOLAB INC.'s latest earnings 8-K →
Look up any company's CIK number →